Orthobiologics Market Set to Reach $8.2 Billion by 2030, Viscosupplementation Segment Exhibiting Robust Growth
DUBLIN, March 12, 2024 /PRNewswire/ -- The "Orthobiologics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Orthobiologics estimated at US$5.9 Billion in the year 2022, is projected to reach a revised size of US$8.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030.
Viscosupplementation, one of the segments analyzed in the Orthobiologics report, is projected to record 5.2% CAGR and reach US$3.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Synthetic Orthobiologics segment is readjusted to a revised 3.5% CAGR for the next 8-year period.
The Orthobiologics market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.
A selection of companies mentioned in this report includes
Arthrex, Inc.
Bioventus
DePuy Synthes
Globus Medical
K2M Group Holdings
Kuros Biosciences
Medtronic
NuVasive
Orthofix International
RTI Surgical, Inc.
SeaSpine Holdings
Stryker Corporation
XTANT Medical Holdings
Zimmer Biomet Holdings
Key Benefits
Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/xw53w2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/orthobiologics-market-set-to-reach-8-2-billion-by-2030--viscosupplementation-segment-exhibiting-robust-growth-302085894.html
SOURCE Research and Markets
